Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
Carcinoma, Renal Cell
Quality of Life
This novel tool indicates that baseline FKSI-15 scores were linked to mPFS and mOS in a clear and interpretable way. The results support evaluation of patient-reported QoL symptoms at baseline as a prognostic indicator of survival in clinical research and practice.